Clear Scientific reports positive CS-1103 Phase 2 Results in removing fentanyl from the Body

Avimer Bio and CNIO publish JACS study on computational design of self‑assembling protein cages

MHRA approves Zepzelca and atezolizumab as first-line maintenance therapy for ES-SCLC in the UK

Pfizer's tilrekimig shows significant skin clearance in Phase 2 atopic dermatitis study

Sanofi and Regeneron expand antibody alliance with four next-generation immunology programmes

AFYREN ingredient enables global launch of natural propionic acid skincare product

Fresenius acquires remaining stake in mAbxience

Lilly reports positive 48-week Phase 2b resu;ts for EloraTZP

Merck reports positive Phase 2b results for tulisokibart in hidradenitis suppurativa

Genentech's fenebrutinib receives FDA priority review for multiple sclerosis

Takeda reports positive Phase 3 psoriasis results for zasocitinib versus deucravacitinib

Oxurion in talks to acquire Eclevar's MedTech CRO business and assets

DBV Technologies submits FDA application for VIASKIN Peanut Patch in children

Vanda Pharmaceuticals reports positive Phase III results for HETLIOZ in Delayed Sleep-Wake Phase Disorder

AstraZeneca invests USD2bn in Summit Therapeutics to advance ADC and cancer-drug combinations